Brain Malformation Clinical Trial
Official title:
Comparison of Abnormal Cortical Development in Brain Malformations on Postmortem Imaging With Autopsy
Examination of the fetal brain at autopsy is technically challenging because of marked fragility of the brain tissue. Studies have found postmortem fetal MR to be particularly useful in examining gross structural abnormalities in fetal brain and spine. We have recently included postmortem MR as part of the radiological studies for fetal autopsy workup. Using the same MR data, the development of normal layering of the brain, also called laminar organization, can also be assessed. This laminar organization of the brain is often disturbed in congenital malformations. Our aim is to study the disturbance in laminar organization of the postmortem brain with MR, using structural MR and a type of MR sequence called diffusion tensor imaging, which is well suited for assessing the organization of the developing brain. The postmortem MR findings will be compared with gold standard of histopathology. This will help us understand the abnormal development of gray and white matter in brain malformations. Knowledge gained from studying the abnormal laminar organization in brain malformations will serve as a reference for future studies of fetal brain malformations in-utero using MRI.
1. Autopsy will be performed at Mount Sinai Hospital according to accepted current
standards, based on clinical indications. Macroscopic examination of the fetus will be
performed initially, followed by organ removal for tissue fixation for a period of two
weeks. The brain is then scanned with MRI at the Hospital for Sick Children. The brain
is transported in an air-tight container containing 10% formalin and sealed with
paraffin lined tape. All brains will be anonymised and coded with a number prior to MRI
examination. Following MR imaging, the tissue will be examined, sampled and reported in
the usual fashion at Mount Sinai Hospital.
2. Postmortem MR will be included as part of the autopsy examination in cases of suspected
brain malformations. Postmortem MR will be performed at the Hospital for Sick Children
due to availability of expertise in postmortem neuroimaging and imaging will be done
using 1.5T GE CV/I MRI magnet (General Electric, Milwaukee, WI). Postmortem MR will be
performed following dissection and tissue fixation to avoid any unnecessary delay in
tissue fixation. The specimen will be scanned in an air-tight container containing
formalin 10%, sealed with paraffin lined tape. Structural postmortem MR will include
coronal spin-echo T1 (TR=517msec, TE=10msec, FOV=18cm, slice thickness=20-30mm,
matrix=320x256), axial SPGR (TR=23msec, TE=8msec, FOV=18cm, slice thickness=1.1mm,
matrix=256x256) and T2 imaging in three planes (TR=4115msec, TE=115msec, FOV=16cm,
slice thickness=20-30mm, matrix=320x256). Diffusion tensor imaging (TR=8300msec,
TE=99msec, FOV=180mm, slice thickness=2-3mm, b=700mm/sec2, NEX=8, matrix=128x128, 25
directions) will be performed in the coronal plane to match the histological sections
of brain tissue in autopsy.
3. Analysis. The laminar organization of the fetal cerebrum on structural MR and diffusion
tensor imaging will be evaluated. In particular, the germinal matrix, intermediate
zone, subplate and cortex will be assessed. This will be compared with the gold
standard of histopathology. The presence or absence of corticospinal tracts will also
be assessed and compared with macroscopic examination and histological sections.
4. Statistical analysis. The sensitivity, specificity and accuracy of postmortem MR, both
structural and diffusion tensor imaging, as compared to the gold standard of autopsy in
assessing the abnormal laminar organization of fetal cerebrum will be evaluated.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03548779 -
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
|
N/A | |
Recruiting |
NCT05790473 -
Artificial Intelligence Algorithm for the Screening of Abnormal Fetal Brain Findings at First Trimester Ultrasound Scan
|
||
Not yet recruiting |
NCT03786497 -
Protecting Brains and Saving Futures - the PBSF Protocol
|
||
Recruiting |
NCT00041600 -
Human Epilepsy Genetics--Neuronal Migration Disorders Study
|